My own area does not cover the economics of health care. I'm certainly familiar with the long-term discussions on a national pharmacare program. From a research point of view, we would favour that very much because it would release a purchasing procurement across the country, if that were organized through a national system. It would also create quality and consistency across the system.
Related to the topic that I was talking about, which was antimicrobial stewardship, it would also allow stewardship through the pharmacare program. It's more than just having an insurance policy for drugs. From that point of view, I would totally support a national pharmacare program.